issues with glp 1 drugs GLP-1 Medications Infographic GLP-1 nausea: How to handle

Indeed, early retrospective cohort studies and post-hoc analyses suggested that GLP-1RAs might delay DR progression or improve outcomes, with one study reporting that 80% of patients on continuous therapy achieved either improvement or stabilization of their DR status [78, 79]

The extensiveness of their overall health benefits has made them one of the primary therapeutic choices for T2DM patients

Current evidence suggests that GLP-1 medications, when used with appropriate patient selection and monitoring, likely do not pose significant long-term threats to vision for most patients and may contribute to better overall ocular outcomes through improved metabolic control

Vallon V

Antidiabetogenic effect of glucagon-like peptide-1 (736)amide in normal subjects and patients with diabetes mellitus

Alvarez E, Roncero I, Chowen JA, Thorens B, Blzquez E